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Abstract
The purpose of the present work was to examine the eﬀect of diﬀerent Ti–6Al–4V surface treatments on osteoblasts behaviour.
Previous work in this laboratory has demonstrated that an ageing treatment reduces metal ion release from this alloy compared to
standard passivation procedures. In this study, human osteosarcoma MG-63 were used in short-term in vitro tests to assay for cell
viability and cell proliferation at 12, 24 and 72 h while SaOS-2 were used in long-term in vitro tests to assay for osteonectin,
osteopontin, osteocalcin gene expression, total protein amount (TP), alkaline phosphatase activity (ALP) and ﬁbronectin
production (FN) for 1–4 weeks. Epiﬂuorescence microscopy was used to observe SaOS-2 cell morphology. After 24 h, there was no
diﬀerence in MG-63 cell viability/proliferation or in SaOS-2 cell morphology between the diﬀerent surface treatments. For the long-
term tests, the aged Ti–6Al–4V induced signiﬁcantly higher cell proliferation than the control Ti–6Al–4V at 72 h. At week 1, no
diﬀerence in the osteonectin, osteopontin, and osteocalcin gene expression was found between samples. The peak of ALP activity
appeared earlier at week 2 for the control surface compared with the passivated and aged surfaces. The early increase in ALP activity
for the control sample could be a compensatory eﬀect of decreased osteoblasts proliferation. There was no diﬀerence in the
expression of FN for the diﬀerent surface treatments. Our present results showed that the diﬀerent surface treatments, which
induced diﬀerent metal ion release kinetics and surface properties, inﬂuenced the cell proliferation and ALP activity of osteoblast
cells. Aluminium ions release kinetics as well as presence of vanadium ions may play a major role in inﬂuencing the osteoblasts
behaviour in the present study. r 2002 Elsevier Science Ltd. All rights reserved.
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1. Introduction
The interaction between solid surfaces and biological
systems are critically important to many areas of
medicine, technology and research. In general, only the
surface of an implant is in direct contact with the host
tissue, and thus this portion of the material plays a
central role in determining its biocompatibility. The
surface of material can change with time, and is often
distinctly diﬀerent from the bulk properties, because of
oxidation and contamination. Although the surface
clearly plays an important role in implant/cell interac-
tions, the relationships between surfaces of the implant,
its reactivity with tissue constituents, and long-term
integrity and clinical eﬃcacy are still poorly understood
[1,2].
Ti–6Al–4V alloy has become one of the most used
biomaterials due to its excellent corrosion resistance,
good mechanical properties and low toxicity [3]. Its
corrosion resistance is due to the oxide ﬁlm, which forms
spontaneously on exposure to air. However, when the
titanium alloy is implanted into a complicated and
aggressive physiological in vivo environment, the oxide
stability may be aﬀected, resulting in increased metal ion
release [4]. Elevated levels of metal ions have been
reported in the serum of patients with both well
functioning and failed total joint replacements [5]. In
addition, aluminium (Al) has well documented toxic
eﬀects in the serum or urine of patients who had a total
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hip replacement made of titanium alloy [6]. Several
in vitro studies have been carried out with a variety of
cell lines to test metal ion toxicity, which is suspected of
playing a signiﬁcant role in cell behaviour. Titanium
ions have been shown to inﬂuence mineral formation
and osteoid nodules in rat calvaria cultures [7]. It has
been demonstrated that Ti–6Al–4V ion solution can
aﬀect the normal diﬀerentiation of bone marrow
stromal cells to mature osteoblasts in vitro [8]. There-
fore, decreasing the metal ion release could be a method
to increase the biocompatibility of Ti alloy.
In our previous work, it has been shown that a simple
thermal treatment, ageing in deionised distilled boiling
water, improves the dissolution resistance of Ti–6Al–4V
alloy compared to conventional passivation treatments
[9]. In the present study, the biocompatibility of the aged
surface was evaluated in comparison to the control and
the passivation treatments. Short- and long-term in vitro
tests were performed with two osteoblastic cell corre-
sponding to immature and mature cells. The biocompat-
ibility of the aged titanium alloy was evaluated in vitro
with short-term tests assessing cell viability, cell
proliferation and cell morphology. Then, quantiﬁcation
of the ageing treatment was performed with long-term in
vitro tests quantifying osteonectin, osteopontin, osteo-
calcin gene expression, FN production, ALP activity
and TP amount.
2. Materials and methods
2.1. Ti alloy surface preparations
Distal sections of forged Ti–6Al–4V alloy femoral
stems from the Ti-Mod Freeman hip replacement were
supplied by Finsbury Instruments (Leatherhead, Surrey,
UK). The hip stems were cut into discs of 4 and 10mm2
and of 1mm thickness. The samples were ﬁrst wet-
ground with 120, 600, 1200, 2400 and 4000 grit silicon
carbide abrasive paper (Struers, UK) at approximately
150 rpm, then polished with 6, 3 and 1 mm diamond
solution (Microcloth Buehler, UK) on a clean polishing
cloth (Microcloth Buehler, UK) and ﬁnally with
colloidal silica polishing suspension (0.06 mm, Master-
met Buehler, UK). Following polishing, the samples
were cleaned in 1% Triton solution for 1 h and rinsed in
deionised distilled water. This treatment was used as a
control (C). The practice for surface preparation of
surgical implants involves a nitric acid passivation
treatment (P) based on the ASTM F86 protocol using
30% nitric acid for 1 h [10]. A third treatment (the
ageing treatment, A) consisted of the passivated treat-
ment followed by ageing in boiling deionised distilled
water for 10 h. The successive steps of the three surface
treatments are shown in Table 1. Finally, the discs were
rinsed several times with sterile, endotoxin-free PBS
before cells were seeded. As preliminary experiments,
the endotoxin assay using Limulus Amebocyte Lysate
(BioWhittaker, Emerainville, France) revealed that no
contamination of lipopolysaccharides (LPS) was present
on the surface of the treated samples.
2.2. Cell culture
Two human osteoblast-like cell lines obtained from
American Tissue Culture Collection (Manassas, VA,
USA) were tested: an immature osteoblast (MG-63) and
a mature osteoblast (SaOS-2) [11]. Two cell lines were
used as it has been shown that cellular response depends
on the local environment as well as on cell state of
maturation [12]. The osteoblasts were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Sigma,
Buchs, Switzerland) containing 10% fetal bovine serum
(Sigma), 1% PSF (100 , 10,000U/ml Penicillin,
10,000 mg/ml Streptomycin and 25 mg/ml Fungizones)
(GibcoBRL, Life Technologies, Basel, Switzerland)
under a humidiﬁed 5% CO2 air atmosphere at 371C.
MG-63 cells were seeded: (1) at a concentration of
5000 cells/well on 4mm2 samples (C, P, A) for cell
proliferation assessment in 96 well cell culture plates;
Table 1
The successive steps of surface treatments for the control (C), the passivated (P) and the aged (A) Ti–6Al–4V surfaces
Control (C) Passivated (P) Aged (A)
Surface preparation Polished
Cleaning in 1% Triton for 1 h
Rinsing in deionised distilled water
Polished
Cleaning in 1% Triton for 1 h
Rinsing in deionised distilled water
30% nitric acid for 1 h
Rinsing in deionised distilled water
Polished
Cleaning in 1% Triton for 1 h
Rinsing in deionised distilled water
30% nitric acid for 1 h
Rinsing in deionised distilled water
10 h in boiling deionised distilled water
Sterilisation Immersed in 100% ethanol for 10min
Air-dried
Exposed under UV light for 30min on each side
Rinsing in endotoxin free phosphate buﬀered solution (PBS)
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(2) at a concentration of 100,000 cells/well on 10mm2
samples (C, P, A) for cell viability assessment in 24 well
cell culture. Proliferation and viability measurements
were performed at 12, 24 and 72 h. SaOS-2 cells were
seeded at a concentration of 100,000 cells/well on
10mm2 samples (C, P, A) for quantiﬁcation of
osteonectin, osteopontin, osteocalcin gene expression
at week 1 and ALP activity, FN and TP at week 1, 2, 3
and 4. The medium was changed every 3–4 days. For
ALP, FN and TP measurements, the medium was
removed two days before each time point (at week 1, 2, 3
and 4) and cells were washed 3 times with PBS to avoid
the eﬀects of serum composition on the biochemical
assays. The cell culture was then incubated with serum
free medium 2 days before biochemical assays.
2.3. Cell viability/proliferation
To assay cell viability, cells were collected by
trypsinisation with 1 trypsin-EDTA solution (Sigma)
5min. The collected cells were double stained with
25 mg/ml ﬂuorescein diacetate (Sigma) and with 20 mg/ml
propidium iodide (Sigma) in PBS for 5min [13]. Live
cells appear green and dead cells appeared red under
epiﬂuorescent illumination (blue ﬁlter of 450–490 nm
and green ﬁlter of 510–560 nm which allowed visualisa-
tion of the green and red ﬂuorescing cell, respectively).
Cell viability tests were performed three times for each
point and at least 200 cells were counted in the
epiﬂuorescent mode of a Nikon Microphot-FXA
microscope (Nikon, Tokyo, Japan). Cell viability was
deﬁned as the ratio of viable cells to the total number
of cells and presented in percentage (%) for the
treatments (C, P, A). To assay cell proliferation, cells
were treated with CellTiter 96s AQueous Assay (Prome-
ga Corp., WI, USA). The assay is based on the
reduction of a tetrazolium compound to a coloured
formazan product by viable cells (or metabolic activity).
The absorbance at 490 nm is directly proportional to the
cell proliferation. The cell proliferation of the passivated
(P) and the aged (A) samples was normalised by the
control (C).
2.4. Osteonectin, osteopontin, osteocalcin
gene expression
Cell lysate was collected after week 1 and total RNA
was isolated and puriﬁed with RNeasy columns (Qiagen,
Basel). The isolated RNA was reversed transcripted to
cDNA with the StratScript enzyme (Stratagene, San
Diego, CA). Quantitative real time RT-PCR (TaqMan
ABI Prism 7700, Applied Biosystem, Foster City, CA)
was used to measure the gene expression of osteonectin,
osteopontin, osteocalcin, and 18S using Ampliﬂuor
Universal Detection System (Intergen, Purchase, NY).
Primers were designed with the Software Primer
Expresst (Applied Biosystem). Primers were purchased
from Integrated DNA Technologies (Coralville, IA).
Use of a housekeeping gene (18S) allowed the diﬀerent
samples to be normalized and compared between
experiments.
2.5. Total protein
A solution of 0.5ml 1% Triton-X in MilliQ water was
used to lyse cells. The lysate was sonicated for 30 s at
40W. The total protein amount was measured in the cell
lysate with DC (Detergent Compatible) Protein Assay
Kit (Bio-Rad Lab, CA, USA).
2.6. Alkaline phosphatase activity
ALP activity is considered to reﬂect osteoblastic
activity and is thought to play a major role in bone
formation and mineralisation [14]. The enzyme activity
within the lysate was measured with a commercial Kit
(Sigma ALP-10, cat. no.245). One unit of LPA activity is
deﬁned as that amount of enzyme, which produces
1 mmol of p-nitrophenol (PNP)/min. The total protein
amount was used to normalise the ALP activity.
2.7. Fibronectin measurement
FN is one of the most abundant extracellular matrix
components in many tissues and has been shown to be
present in early bone formation [15]. A commercially
available Human Fibronectin ELISA kit (Biomedical
Tech Inc., Stoughton, MA, USA) was used to measure
FN within the lysate. The FN production was norma-
lised by the total protein amount.
2.8. Statistical analysis
The viability and proliferation of MG-63 are pre-
sented at each time point (12, 24, and 72 h) correspond-
ing to the mean7standard error of three independent
analyses. Gene expression results of SaOS-2 are
presented at week 1 and corresponded to the mean7
standard error of three independent analyses performed
in duplicates. The ALP activity and FN normalised by
TP of SaOS-2 are presented at each time point (1, 2, 3
and 4 weeks) corresponding to the mean7standard
error of four independent analyses performed in
duplicates. ANOVA was used to determine the stati-
stical signiﬁcance of the diﬀerences observed between
groups. p values smaller than 0.05 were considered
signiﬁcant.
2.9. Cell morphology
Cell morphology studies can provide information
concerning the cell interaction with the treated
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Ti–6Al–4V implant and cell–cell contact. SaOS-2 cells
were seeded on to each sample (10mm2) at a concentra-
tion of 2000 cells/well in 24-well tissue culture plates for
24 h and 7 days. Cells were then ﬁxed with 1%
glutaraldehyde (Sigma) in PBS, treated with 1% Triton
X, 2mg/ml sodium borohydride (Sigma) in PBS and
stained with 4 mg/ml rhodamin-phalloidin (Sigma) for
actin microﬁlaments. A Nikon Eclipse TE300 inverted
epiﬂuorescence microscope enabled cells to be visua-
lised. A Standard ﬁlter set (510 nm) was used for
rhodamin-phalloidin. Images were acquired with a
Micromax PB1300 cooled CCD camera (Roper Scien-
tiﬁc, Trenton, NJ) and image contrast enhancing was
performed using a MetaMorph imaging system (Uni-
versal Imaging Corporation, Westchester, PA). The cell
morphology and particularly the actin ﬁlament organi-
sation were visually examined.
3. Results
3.1. Cell viability/proliferation
There was no signiﬁcant diﬀerence between the
three diﬀerent treated samples for the cell viability of
MG-63 during the test (Fig. 1). The aged sample had
higher cell proliferation compared to the passivated
samples at 72 h (Fig. 2).
3.2. Osteonectin, osteopontin, osteocalcin
gene expression
There was no signiﬁcant diﬀerence between the three
diﬀerent treated samples for the osteonectin, osteopon-
tin, and osteocalcin gene expression of SaOS-2 at week 1
(Fig. 3). The level of gene expression was comparable
for osteonectin and osteopontin for each sample while
higher level was found for osteocalcin of MG-63 during
the test (Fig. 1).
3.3. Alkaline phosphatase activity
The ALP activity of the control sample was statisti-
cally higher than the passivated and the aged samples at
week 2 (Fig. 4). At week 4, the aged sample induced a
statistically higher ALP activity than the passivated and
the control samples.
3.4. Fibronectin measurement
No FN activity was detected at week 1 (Fig. 5). FN
activity was observed after week 2 and reached a peak at
Fig. 1. Viability of MG-63 cells on the diﬀerent Ti–6Al–4V samples.
There was no signiﬁcant diﬀerence between the three diﬀerent treated
samples (C: control, P: passivated; A: aged) for the MG-63 cell
viability at 12, 24, and 72 h.
Fig. 2. Proliferation of MG-63 cells on the diﬀerent Ti–6Al–4V
samples. The proliferation of P and A was normalised by the
proliferation of C. A signiﬁcant diﬀerence between the aged and
passivated samples was found at 72 h (*: pp0.05; P: passivated;
A: aged).
Fig. 3. Gene expression of osteonectin, osteopontin, and osteocalcin
normalised by the gene expression of 18S on the diﬀerent Ti–6Al–4V
samples. There was no signiﬁcant diﬀerence between the three diﬀerent
treated samples (C: control, P: passivated; A: aged) for the SaOS-2
cells gene expression at week 1.
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week 3 before decreasing at week 4. There was no
signiﬁcant diﬀerence among the three surface treat-
ments.
3.5. Cell morphology
After 24 h, bundles of actin ﬁlaments (stress ﬁbres)
were found and cells had an angular shape on the three
diﬀerent treated surfaces. Focal adhesion and some
small stress ﬁbres were also visible at the cells periphery
(Fig. 6). After 7 days, cell–cell contact was visualised for
the osteoblasts on these three surface treatments. No
major diﬀerence was visually found between the three
surface treatments.
4. Discussion
In short-term in vitro tests (24 h), cell viability/
proliferation and cell morphology demonstrated no
evidence of cell toxicity in response to the diﬀerent
treated Ti–6Al–4V surfaces. Moreover, the cell mor-
phology of SaOS-2 clearly showed that focal adhesion
sites localised at the periphery and bundles of actin
ﬁlaments spanned the entire cells when cells were seeded
on the three diﬀerent samples (Fig. 6). Based on these
results, it was not possible to discriminate the eﬀects of
the diﬀerent surface treatments on oseteoblasts beha-
viour.
Diﬀerences between osteoblasts behaviour became
apparent only since 72 h with a signiﬁcant diﬀerence in
proliferation between the aged and the passivated
samples (Fig. 2). The proliferation measurement was
based on cellular reduction of MTS and was dependent
on the reduced pyridine nucleotides NADH and
NADPH, i.e. ﬁnally on mitochondrial activity. The
cellular damage in mitochondria inevitably results in
loss of the ability of the cell to maintain and provide
energy for metabolic cell function and growth [16].
Decrease in cell proliferation suggests that metal
ion release may indeed aﬀect mitochondrial activity.
Nevertheless, this hypothesis needs to be further
conﬁrmed.
It has been found that by aﬀecting their proliferation,
osteoblasts may delay the time course of their diﬀer-
entiation stages e.g. [17]. In the present study, we
showed that metal ion release from the diﬀerent surface
treatments aﬀected the cell proliferation. Therefore, it
seems reasonable to assume that the diﬀerent surface
treatments may shift the time course of diﬀerentiation
stage. A delay in the peak measurement of ALP activity
was noted on the aged and the passivated samples
compared to the control sample (Fig. 4). Even though
results comparisons between two diﬀerent cell lines
should be handled carefully, it seems that the decrease of
MG-63 proliferation and the delay in the peak
measurement of SaOS-2 ALP activity agrees with the
assumption mentioned that surface treatment could
delay the diﬀerentiation pathway of the osteoblasts.
A similar result has been demonstrated in a previous
study [18].
The osteocalcin, osteopontin and osteonectin are
important osteoblastic markers and are expressed at
diﬀerent maturation stages of the osteoblasts [19]. These
three genes have been shown to be diﬀerently involved
in the bone mineralization process. Osteocalcin, which is
the most osteoblast-speciﬁc gene yet known [20], has
been demonstrated to stimulate bone mineral matura-
tion [21]. Osteopontin has been shown to inhibit the
crystal growth of hydroxyapatite e.g. [22], while
osteonectin has been suggested to promote collagen
mineralization [23]. In the present study, no diﬀerence in
Fig. 5. Fibronectin measurements of SaOS-2 cells on the diﬀerent Ti–
6Al–4V samples. No ﬁbronectin was detected for all samples at week 1.
There was no signiﬁcant diﬀerence between the three diﬀerent treated
samples (C: control, P: passivated; A: aged) for the SaOS-2 cells
ﬁbronectin production at week 2, 3, and 4.
Fig. 4. ALP activity of SaOS-2 cells on the treated Ti–6Al–4V samples
(C: control, P: passivated, A: aged). At week 2, there was a signiﬁcant
diﬀerence between C versus P and between C versus A (*: pp0.05). At
week 4, there was a signiﬁcant diﬀerence between C versus A and
between P versus A (+: pp0.05).
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osteocalcin, osteopontin and osteonectin gene expres-
sion was found at week 1 between the samples. The
diﬀerent surface treatments seen then not to induce a
diﬀerent mineralization process, at least during the ﬁrst
week.
No FN was detected at week 1. Other proteins such as
collagen may play a major role in the cell attachment to
the diﬀerent samples instead of FN at week 1 e.g. [24]. It
may also be possible that the metal ion release from the
samples aﬀected the initial production of FN. A
previous study has demonstrated that FN was not
involved in the adhesion of osteoblasts to uncoated Ti
alloy at 24 h [25]. Moreover, the integrin a5Fwhich is a
major adhesion receptor of osteoblasts interacting with
FN [26,27]Fwas not detected in cell cultured on
polished or rough Ti–6A1–4V at 12 h while it was
detected for cell cultured on polystyrene [28]. Despite
results of the study by Sinha and Tuan [28] were
obtained at 12 h while present FN results were obtained
at week 1, they could support the hypothesis that
proteins other than FN were involved in the osteoblast
adhesion to Ti alloy. The production of FN observed
Fig. 6. Morphology of SaOS-2 cells seeded on the diﬀerent Ti–6Al–4V samples at 24 h (C-24 h, P-24 h, A-24 h) and 7 days (C-7 d, P-7 d, A-7 d) (C:
control, P: passivated; A: aged). Actin ﬁlaments and focal adhesion points were clearly visible at 24 h.
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after two weeks could then probably be due to cell–cell
contact e.g. [29]. The increasing FN production at
week 2 and 3 could also contribute to cell spreading
conﬁguration maintaining the survival of mature
osteoblasts [30].
Previous work in our group has demonstrated that the
diﬀerent surface treatments alter the metal ion release
kinetics and surface composition of the Ti–6A1–4V
alloy [9,31]. The release of A1 ions was found to be
about 0.84 mm for the ageing treatment and about
5.55 mm for the passivation treatment after 7 days [9].
The osteoblasts cultured on the aged surface experienced
therefore, a much lower concentration of A1 ions during
the test duration. The kinetics of the metal ion
dissolution, especially for A1, could then explain the
diﬀerences in cell behaviour, which were observed only
in long-term in vitro study. Indeed, results of ALP peak
activity at week 2 for the control treatment compared to
the passivated and aged treatments was in agreement
with a previous study using a similar A1 ion concentra-
tion [32]. It should be noted also that the only diﬀerence
in terms of ion release composition between the diﬀerent
Ti–6A1–4V surface treatments was the presence of
vanadium for the control treatment. It may be possible
therefore, that vanadium also has an impact on
osteoblast diﬀerentiation by maturing the osteoblasts
faster. Further experiments on this particular hypothesis
need to be performed before a deﬁnitive conclusion can
be drawn.
It has been shown that surface roughness inﬂuenced
the cell behaviour [12]. We have used XPS and AFM
techniques to examine the surface properties of the
treated Ti–6Al–4V surfaces [33]. A diﬀerence in rough-
ness (Ra) between the passivated and the aged samples
could only be observed at a small scale (1 mm2). The area
average Ra was about 0.99 nm (C), 1.29 nm (P) and
0.56 nm (A). Therefore, at the cell level, the roughness
could be considered as similar between samples and
could not explain the diﬀerences in osteoblasts beha-
viour.
Biocompatibility tests such as those performed in
this study can only quantify particular aspects of
cell behaviour. The cell reaction to an implant is
however a very complex situation and can only be
partially understood using standard biological assays.
In order to have a comprehensive description of the
cell–implant interaction with surface treated Ti
alloy, cDNA microarray technology may be performed
e.g. [34,35]. This represents the next step of this
study.
5. Conclusions
In this study, short-term (24 h) in vitro experiments
demonstrated that diﬀerent Ti–6Al–4V surface treat-
ments had negligible eﬀects on the measured para-
meters. Cell viability remained unaﬀected and cell
morphology expressed rich actin ﬁlaments. In longer
in vitro experiments (from 72 h until 4 weeks), the
diﬀerence in the kinetics of metal ion dissolution
between treatments is more important and consequently
a higher cell proliferation on the aged sample and an
accelerated peak of ALP activity on the control sample
were observed. Osteonectin, osteopontin, and osteocal-
cin gene expression (at week 1) as well as FN production
(until week 4) were not aﬀected by the diﬀerent surface
treatments. Based on our previous metal ion release
studies and surface analyses, A1 ions release kinetics as
well as presence of vanadium ions may play a major role
in inﬂuencing the osteoblasts behaviour in the present
study.
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